(DLHC) DLH Holdings - Ratings and Ratios

DLH Holdings Corp is a US-based company providing technology-enabled business process outsourcing, program management, and public health research services to government agencies, including the National Institutes of Health, Defense Health Agency, and Department of Veterans Affairs. The companys services encompass digital transformation, cybersecurity, artificial intelligence, and data analytics, supporting various federal clients. With a history dating back to 1969, DLH Holdings Corp has evolved to become a key player in the human resource and employment services sector.

The companys diverse service portfolio includes science research and development, system engineering, and integration solutions, as well as business process management services, leveraging cloud-based solutions like e-PRAT, SPOT-m, and Infinibyte. DLH Holdings Corps expertise in data analytics, testing and evaluation, and epidemiology studies supports multiple operating divisions, including the NIH and the Center for Disease Control and Prevention. The companys capabilities in artificial intelligence, machine learning, and big data analytics position it for potential growth in the government contracting space.

Analyzing the provided technical and fundamental data, DLH Holdings Corps stock has experienced significant volatility, with a 52-week high of $12.12 and a low of $2.74. The current price of $5.09 is above its 20-day and 50-day simple moving averages, indicating a potential short-term uptrend. However, the stock remains below its 200-day SMA, suggesting a longer-term downtrend. The Average True Range (ATR) of 0.30 represents a 5.88% daily price range, indicating moderate volatility.

Considering the fundamental data, DLH Holdings Corps market capitalization is approximately $66.18 million, with a price-to-earnings ratio of 10.45 and a forward P/E of 17.45. The companys return on equity is 4.90%. Based on the technical and fundamental analysis, a potential forecast is that DLH Holdings Corps stock may experience a short-term rally, driven by its recent uptrend and government contracting opportunities. However, the long-term downtrend and moderate volatility necessitate caution. A potential price target could be around $7-8, representing a 30-50% increase from the current price, contingent upon the companys ability to secure new contracts and demonstrate improved profitability.